Enabling global access to diagnostics.

OUR STORY

GlowDX was established in 2015, and embarked upon a research and development program to develop an accessible diagnostic platform for developing countries. Right now we are in our first phase; bringing products to existing molecular platforms, while our Point-of-Care platform is in development. We aim to launch our Point-of-Care platform in 2021; bringing a fully integrated sample preparation & molecular diagnostic system to those who need it most!

Enabling Early Diagnosis

Improving Clinical Outcome

Reducing Economic Burden

OUR PRODUCTS

GlowDX is focused on delivering high quality products that translate into meaningful clinical interventions. We strive to democratise molecular diagnostics, reducing Disability Adjusted Life Years (DALYs) and improving quality of life.

IN THE NEWS

JOIN THE JOURNEY

SIGN UP TO GET THE LATEST NEWS AND INFO ABOUT OUR EMERGING PRODUCTS.